Home
Team
Portfolio
Blog
Contact
Investors
More
Our Recent Posts
OrthAlign Receives FDA 510(k) Clearance for Lantern® Hip
Catalyst OrthoScience Surpasses 10,000 Total Shoulder Arthroplasty (TSA) Procedures and Announces $20 Million Financing
RevLocal Acquired by Hibu, an H.I.G. Capital Portfolio Company
Archive
SPR Therapeutics Unveiled New Datasets on SPRINT® PNS at ASPN 2023
OrthAlign's Handheld Nav System Hits 300,000 Case Milestone
Catalyst OrthoScience Announces Mark Quick as CFO